Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS: INTI · Delayed Price · USD
0.0800
+0.0075 (10.34%)
Jul 23, 2024, 3:55 PM EDT - Market closed
Inhibitor Therapeutics Employees
As of December 31, 2023, Inhibitor Therapeutics had 9 total employees, including 3 full-time and 6 part-time employees. The number of employees increased by 3 or 50.00% compared to the previous year.
Employees
9
Change (1Y)
3
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$352,361
Market Cap
13.79M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
INTI News
- 7 months ago - Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory Board - PRNewsWire
- 7 months ago - Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University - PRNewsWire